A multicentre evaluation of the medtronic AVE flexible iliac bridge stent in the iliac arteries (the First Study)

  • P.A. G
  • K.-L. S
  • S. M
  • et al.
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: To investigate the short term and 6 month outcomes of a recently introduced iliac stent (the Medtronic AVE Flexible Iliac Bridge Stent). Method: One hundred and sixteen patients, 122 limbs from 6 European sites with atherosclerotic occlusive disease were included if they either had a full occlusion or there was a residual gradient >10 mmHg following PTA. Clinical, haemodynamic and Duplex outcomes were recorded to 6 months. Results: After stent placement there was no residual stenosis >30 and 8.1% of segments had a residual resting gradient of >10 mmHg. There were three local complications and three deaths at 30 days. Primary patency at 30 days and 6 months was 94.1 and 82.7%. Marked clinical improvement occurred in 87.6 and 86.2% at 30 days and 6 months. Conclusion: The Medtronic AVE iliac stent has good 30 day and 6 months outcomes supporting the effective use of this device in occlusive disease. © 2004 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

P.A., G., K.-L., S., S., M.-H., J., S., G., M., H., van O., & T.J., C. (2005). A multicentre evaluation of the medtronic AVE flexible iliac bridge stent in the iliac arteries (the First Study). European Journal of Vascular and Endovascular Surgery, 29(2), 124–130. https://doi.org/10.1016/j.ejvs.2004.12.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free